IS T-FACTOR OF THE TNM STAGING SYSTEM A PREDOMINANT PROGNOSTIC FACTOR IN PATHOLOGICAL STAGE-I NON-SMALL-CELL LUNG-CANCER - A MULTIVARIATE PROGNOSTIC FACTOR-ANALYSIS OF 151 PATIENTS

被引:75
作者
ICHINOSE, Y [1 ]
HARA, N [1 ]
OHTA, M [1 ]
YANO, T [1 ]
MAEDA, K [1 ]
ASOH, H [1 ]
KATSUDA, Y [1 ]
机构
[1] NATL KYUSHU CANC CTR,DEPT PATHOL,MINAMI KU,FUKUOKA,JAPAN
关键词
D O I
10.1016/S0022-5223(19)33744-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We attempted to clarify whether the T factor of the TNM staging system should be viewed as a predominant prognostic factor in patients with pathologic stage I non-small-cell lung cancer when analyzed together with various histopathologic factors and deoxyribonucleic acid ploidy pattern of tumors. We studied 151 patients who were in this stage. Histopathologic factors used in the analysis were as follows: histologic cell type (squamous or nonsquamous cell carcinoma), grade of differentiation, and tumor invasion of visceral pleura and vessels. Deoxyribonucleic acid ploidy pattern of tumors was analyzed by flow cytometry, and the tumors were classified as diploid or aneuploid tumors. Significant prognostic factors (p < 0.05) that were demonstrated by univariate analysis of survival curves were as follows: (1) T1 versus T2; (2) well versus moderately or poorly differentiated tumor; (3) the absence versus presence of tumor exposed on pleura, (4) artery invasion, (5) lymphatic vessel invasion; and (6) diploid versus aneuploid tumor. Multivariate prognostic factor analysis showed the grade of differentiation and deoxyribonucleic acid ploidy pattern to be predominant prognostic factors. The T2 tumor group had significantly more cases with tumor invasion of lymphatic vessels than did the T1 tumor group and included 18 cases with tumor exposed on pleura. When these two factors were excluded from multivariate analysis, the T factor was marginally significant (p = 0.08). These observations suggest that the T factor is not necessarily a predominant prognostic factor in pathologic stage I non-small-cell lung cancer.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 23 条
  • [1] CIBAS ES, 1989, CANCER, V63, P1552, DOI 10.1002/1097-0142(19890415)63:8<1552::AID-CNCR2820630817>3.0.CO
  • [2] 2-F
  • [3] COX DR, 1972, J R STAT SOC B, V34, P187
  • [4] SITES OF RECURRENCE IN RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER - A GUIDE FOR FUTURE STUDIES
    FELD, R
    RUBINSTEIN, LV
    WEISENBERGER, TH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) : 1352 - 1358
  • [5] POSTOPERATIVE ADJUVANT CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - PROGNOSTIC VALUE OF DNA PLOIDY AND POSTRECURRENT SURVIVAL
    ICHINOSE, Y
    HARA, N
    OHTA, M
    MOTOHIRO, A
    KUDA, T
    ASO, H
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1991, 46 (01) : 15 - 20
  • [6] MARTINI N, 1983, J THORAC CARDIOV SUR, V86, P646
  • [7] MERLIER M, 1985, LUNG CANCER, V1, P27
  • [8] MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4_Supplement.225S
  • [9] LUNG-CANCER CLASSIFICATION - THE RELATIONSHIP OF DISEASE EXTENT AND CELL TYPE TO SURVIVAL IN A CLINICAL-TRIALS POPULATION
    MOUNTAIN, CF
    LUKEMAN, JM
    HAMMAR, SP
    CHAMBERLAIN, DW
    COULSON, WF
    PAGE, DL
    VICTOR, TA
    WEILAND, LH
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1987, 35 (03) : 147 - 156
  • [10] RELATIONSHIP BETWEEN DNA PLOIDY, ANTIGEN EXPRESSION AND SURVIVAL IN RENAL-CELL CARCINOMA
    OOSTERWIJK, E
    WARNAAR, SO
    ZWARTENDIJK, J
    VANDERVELDE, EA
    FLEUREN, GJ
    CORNELISSE, CJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) : 703 - 708